Study to Evaluate the Efficacy and Safety of DA-1241 in Subjects With Presumed NASH

NCT06054815 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

109

Enrollment

INDUSTRY

Sponsor class

Conditions

NON-ALCOHOLIC STEATOHEPATITIS

Interventions

DRUG: DA-1241
DRUG: Sitagliptin
DRUG: DA-1241 Placebo
DRUG: Sitagliptin Placebo

Sponsor

NeuroBo Pharmaceuticals Inc.